B
TMO icon

Bellecapital’s Thermo Fisher Scientific TMO Stock Holding History

Bellecapital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.42M Buy
18,781
+2,743
+17% +$1.32M 1.51% 23
2026
Q1 		$7.88M Buy
16,038
+911
+6% +$494K 1.42% 27
2025
Q4 		$8.77M Sell
15,127
-246
-2% -$139K 1.56% 23
2025
Q3 		$7.46M Buy
15,373
+877
+6% +$408K 1.2% 26
2025
Q2 		$5.88M Buy
14,496
+1,443
+11% +$603K 1.04% 28
2025
Q1 		$6.5M Buy
13,053
+379
+3% +$205K 1.28% 27
2024
Q4 		$6.59M Buy
12,674
+2,506
+25% +$1.38M 1.16% 27
2024
Q3 		$6.29M Buy
10,168
+703
+7% +$416K 1.25% 25
2024
Q2 		$5.23M Buy
9,465
+1,384
+17% +$793K 1.11% 27
2024
Q1 		$4.7M Buy
8,081
+703
+10% +$394K 1.04% 31
2023
Q4 		$3.92M Buy
7,378
+282
+4% +$136K 0.89% 33
2023
Q3 		$3.59M Buy
7,096
+168
+2% +$89.5K 0.9% 34
2023
Q2 		$3.61M Buy
6,928
+457
+7% +$247K 0.87% 37
2023
Q1 		$3.73M Buy
6,471
+184
+3% +$104K 0.93% 33
2022
Q4 		$3.46M Sell
6,287
-50
-0.8% -$26.5K 0.97% 33
2022
Q3 		$3.21M Buy
6,337
+1,020
+19% +$571K 0.98% 33
2022
Q2 		$2.89M Buy
5,317
+89
+2% +$49K 0.81% 38
2022
Q1 		$3.09M Buy
5,228
+562
+12% +$323K 0.98% 31
2021
Q4 		$3.11M Buy
4,666
+376
+9% +$235K 0.89% 32
2021
Q3 		$2.45M Buy
4,290
+224
+6% +$123K 0.75% 38
2021
Q2 		$2.05M Sell
4,066
-121
-3% -$57.1K 0.62% 40
2021
Q1 		$1.91M Buy
4,187
+3,262
+353% +$1.56M 0.6% 38
2020
Q4 		$431K Buy
+925
New +$434K 0.14% 120

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bellecapital's TMO Position: Q2 2026 in Review

Bellecapital increased its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, buying an estimated $1.32M and bringing the position to 18,781 shares worth $9.42M. The position accounts for 1.51% of the portfolio, ranked #23.

Bellecapital first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bellecapital held 18,781 shares of Thermo Fisher Scientific worth $9.42M as of Q2 2026.
  • Bellecapital bought 2,743 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.32M.
  • Thermo Fisher Scientific made up 1.51% of Bellecapital's portfolio in Q2 2026, its #23 holding.
  • Bellecapital first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.